Catalyst Reaction · NASDAQ: LYEL · Biotechnology
Lyell Immunopharma (LYEL): Phase 1 data, a 43.3% session and what followed
Lyell Immunopharma (LYEL) released to Present positive updated ronde-cel data in More than 80 patients at 9:01 AM ET on Wednesday, November 4, and the stock went from Tuesday’s $10.77 close to as high as $16.73. It finished the session +43.3% at $15.43 on 6.9 times its 20-day average volume. Here is how it traded, turn by turn, and how LiveChart’s stack read each one.
By IndicatorStack · · All times ET
The catalyst
What the company released or filed, to the minute it crossed. It’s in the timeline as a shaded row, linked to the source.
How it traded
The price around it, session by session: the gap, the range, the close, with the chart LiveChart draws from those bars.
How the stack read it
LiveChart’s read at each turn: the 5-minute trend (the stack bias), the higher timeframes (Compass), the flow (Undertow) and traps (Tripwire).
How the stack read it, checkpoint by checkpoint
The stack bias is LiveChart’s read of the 5-minute trend at that moment: a green dot is bullish, red bearish, grey no clear direction. Under it, what Compass read on the higher timeframes the trend is measured against.
- BeforeBearishTue close · $10.7915m and 1h split
- Into the openBullishWed 9:30 AM · $12.2515m and 1h up
- 30 minutes inBullishWed 10:00 AM · $14.0215m and 1h up
- At the closeNeutralWed 4:00 PM · $15.4715m and 1h up
- Thursday’s closeNeutralThu 4:00 PM · $15.0715m and 1h split
- Friday’s closeBearishFri 4:00 PM · $14.8215m and 1h split
- Monday’s closeBearishMon 4:00 PM · $15.3715m and 1h split
The timeline
Everything that happened, in order, on one ET clock: the company’s releases and SEC filings next to the price and the stack’s own turns.
- ReleaseSECShaded rows are the catalyst: the company’s own releases and filings
- PriceThe session’s open, high, low and close
- StackLiveChart’s 5-minute bias changed
- TriggerA hypothetical entry at the default settings
- TripwireA break of a level that failed to hold
Wednesday, November 4
- ReleaseTo Present positive updated ronde-cel data in More than 80 patientsPress release, GlobeNewsWire
- Release$80 million private placement to Advance Ronde-Cel Toward Planned BLA SubmissionPress release, GlobeNewsWire
- SECCurrent report (Form 8-K) filedAccepted by the SEC at 9:05:07 AM ET
- Stack5-minute stack bias turned bullishat $11.24
- PricePremarket high $12.25+13.7% from the prior close
- PriceSession low $12.09
- PriceOpened at $12.09+12.3% from Tuesday’s $10.77 close
- TripwireTripwire flagged a trap at the highsa push through resistance that failed to hold, at $14.20
- PriceSession high $16.73
- TripwireTripwire flagged a trap at the lowsa push through support that failed to hold, at $14.90
- Stack5-minute stack bias went neutralat $15.33, its inputs no longer agreeing
- Stack5-minute stack bias turned bullishat $15.68
- Stack5-minute stack bias went neutralat $15.11, its inputs no longer agreeing
- TriggerTrigger marked a long at $15.47Hypothetical, default settings: closed at $15.17 at 4:05 PM for −1.9% (stop)
- PriceClosed at $15.43, +43.3% on the day1.1M shares, 6.9× its 20-day average
- ReleaseBusiness highlights and financial results for the third quarter 2026Press release, GlobeNewsWire
- SECCurrent report (Form 8-K) filedAccepted by the SEC at 4:14:24 PM ET
- SECQuarterly report (Form 10-Q) filedAccepted by the SEC at 4:17:48 PM ET
Thursday, November 5
- Stack5-minute stack bias turned bullishat $15.88
- PriceOpened at $15.05−2.5% from Wednesday’s $15.43 close
- Stack5-minute stack bias went neutralat $15.33, its inputs no longer agreeing
- PriceSession high $16.20
- Stack5-minute stack bias turned bullishat $16.05
- Stack5-minute stack bias went neutralat $15.54, its inputs no longer agreeing
- Stack5-minute stack bias turned bearishat $15.45
- PriceSession low $13.69
- Stack5-minute stack bias went neutralat $14.86, its inputs no longer agreeing
- TriggerTrigger marked a short at $14.73Hypothetical, default settings: closed at $15.07 at 3:55 PM for −2.3% (stop)
- PriceClosed at $15.00, −2.8% on the day658K shares, 3.2× its 20-day average
Friday, November 6
- PriceOpened at $15.75+5.0% from Thursday’s $15.00 close
- PriceSession high $16.08
- Stack5-minute stack bias went neutralat $15.25, its inputs no longer agreeing
- Stack5-minute stack bias turned bearishat $15.25
- PriceSession low $14.75
- PriceClosed at $14.86, −0.9% on the day251K shares, 1.1× its 20-day average
Monday, November 9
- PriceSession low $14.76
- PriceOpened at $14.76−0.7% from Friday’s $14.86 close
- Stack5-minute stack bias went neutralat $15.65, its inputs no longer agreeing
- Stack5-minute stack bias turned bullishat $16.31
- PriceSession high $17.11
- Stack5-minute stack bias went neutralat $16.19, its inputs no longer agreeing
- TriggerTrigger marked a short at $16.09Hypothetical, default settings: reached $15.66 at 4:55 PM for +2.7% (trailed from the low)
- Stack5-minute stack bias turned bearishat $15.87
- PriceClosed at $15.42, +3.8% on the day410K shares, 1.7× its 20-day average
Tuesday, November 3
Before the catalyst
Lyell Immunopharma closed Tuesday at $10.77. The 5-minute stack bias was bearish (weakening), since 12:20 PM: under VWAP 10.94 and a falling SMA, momentum down. Compass read “15m and 1h split” (15m ↘ 1h ↗ 2h ↗ 4h ↑ D ↓). Undertow: volume surge, buyers hitting the offer. Tripwire: Shorts: Avoid, resistance looks thin, buying tape on it. Its Next row read “Bounce, resistance to hold at 10.94 (VWAP)”.
Over the year before, it had traded between $7.20 and $45.00. The week before, on Monday, November 2, the company had announced to participate in November investor events at 8:00 AM ET. The daily chart below shows where it was trading, and the bar the catalyst printed.
Bearishweakening · 5m stack bias · $10.79
- Compass
- 15m and 1h split
- Undertow
- Volume surge
- Tripwire
- Shorts: Avoid
- Next
- Bounce, resistance to hold at 10.94 (VWAP)
Wednesday, November 4
The Phase 1 data and a 43.3% session
The release crossed at 9:01 AM ET, with the company’s Form 8-K accepted by the SEC at 9:05 AM. It opened at $12.09, +12.3%, and the regular session ranged from $12.09 to $16.73 before closing at $15.43. It did this on a day SPY rose 1.7% and XBI, the biotechnology ETF, rose 2.7%.
Into the open the stack read it as bullish (strong) with 2 of 2 higher timeframes up, and Undertow read “buyers in control”. Thirty minutes in, the picture had changed: price was below VWAP at $14.39 and the Next row read “Pullback, support to hold at 13.30 (slow EMA)”. By the close the 5-minute bias was neutral, while Compass still read “15m and 1h up”: the day’s trend on the 5-minute chart had turned while the higher timeframes it is measured against had not.
Bullishstrong · 5m stack bias · $12.25
- Compass
- 15m and 1h up
- Undertow
- Buyers in control
- Tripwire
- Longs: Clean
- Next
- Stretched above the averages, pullback area near 11.83
Bullishweakening · 5m stack bias · $14.02
- Compass
- 15m and 1h up
- Undertow
- Volume surge
- Tripwire
- Longs: Clean
- Next
- Pullback, support to hold at 13.30 (slow EMA)
Neutral5m stack bias · $15.47
- Compass
- 15m and 1h up
- Undertow
- Volume surge
- Tripwire
- Longs: Clean
- Next
- Range 15.07 to 15.46, no edge in the middle
Thursday, November 5
The session after
It opened at $15.05 (−2.5%) and traded from $13.69 to $16.20, closing at $15.00, −2.8% on 658K shares, still 3.2 times its 20-day average. The 5-minute stack bias was neutral, its inputs disagreeing. Compass read “15m and 1h split” (15m ↘ 1h ↑ 2h ↑ 4h ↑ D ↗). Undertow: volume surge, buyers hitting the offer. Tripwire: Longs: Caution, heavy tape pushing against it.
Neutral5m stack bias · $15.07
- Compass
- 15m and 1h split
- Undertow
- Volume surge
- Tripwire
- Longs: Caution
- Next
- Coiled 14.71 to 15.16, direction comes on the break
Friday, November 6
The session after
It opened at $15.75 (+5.0%) and traded from $14.75 to $16.08, closing at $14.86, −0.9% on 251K shares, still 1.1 times its 20-day average. The 5-minute stack bias was bearish (firm), since 10:45 AM: under VWAP 15.09 and a falling SMA, momentum down and net selling. Compass read “15m and 1h split” (15m ↘ 1h ↗ 2h ↗ 4h ↗ D ↗). Undertow: volume surge, buyers hitting the offer. Tripwire: Shorts: Clean, nothing major in the way.
Bearishfirm · 5m stack bias · $14.82
- Compass
- 15m and 1h split
- Undertow
- Volume surge
- Tripwire
- Shorts: Clean
- Next
- Selling drying up at 14.73, squeeze risk rising
Monday, November 9
The session after
It opened at $14.76 (−0.7%) and traded from $14.76 to $17.11, closing at $15.42, +3.8% on 410K shares, still 1.7 times its 20-day average. The 5-minute stack bias was bearish (strong), since 3:40 PM: under VWAP 16.10 and a falling SMA, momentum down, net selling and trend strength with the sellers. Compass read “15m and 1h split” (15m ↓ 1h ↗ 2h ↗ 4h ↗ D ↑). Undertow: volume surge, sellers hitting the bid. Tripwire: Shorts: Clean, nothing major in the way.
After hours it last traded at $15.42, with Undertow reading “sellers in control”.
Bearishstrong · 5m stack bias · $15.37
- Compass
- 15m and 1h split
- Undertow
- Volume surge
- Tripwire
- Shorts: Clean
- Next
- Stretched below the averages, bounce area near 15.71
Bearishstrong · 5m stack bias · $15.42
- Compass
- 15m and 1h split
- Undertow
- Sellers in control
- Tripwire
- Shorts: Clean
- Next
- Trend down, fast EMA at 15.46, longs run against the bias
Shares, float and insiders
The supply picture
What the company has outstanding, and what its insiders and its share history show, from its SEC filings.
- Shares outstanding
- 24.6Mas reported to the SEC
- Float
- 14.7M60% of shares outstanding
- Reverse splits on record
- 11-for-20 reverse split, June 2, 2025
- Last insider purchase
- November 4, 20262.3M shares at $10.77 by ARCH Venture Partners IX, LLC (10 percent owner)
- Last insider sale
- November 10, 2026129 shares at $15.93
Releases and filings
Sources
The company’s own releases and its filings with the SEC, newest first, each with the time it crossed.
- SECQuarterly report (Form 10-Q)Wed Nov 4, 4:17 PM ET · SEC EDGAR
- SECCurrent report (Form 8-K)Wed Nov 4, 4:14 PM ET · SEC EDGAR
- ReleaseBusiness highlights and financial results for the third quarter 2026Wed Nov 4, 4:05 PM ET · GlobeNewsWire
- SECCurrent report (Form 8-K)Wed Nov 4, 9:05 AM ET · SEC EDGAR
- Release$80 million private placement to Advance Ronde-Cel Toward Planned BLA SubmissionWed Nov 4, 9:02 AM ET · GlobeNewsWire
- ReleaseTo Present positive updated ronde-cel data in More than 80 patientsWed Nov 4, 9:01 AM ET · GlobeNewsWire
In short
Questions
Why did LYEL stock go up on November 4?
Lyell Immunopharma (LYEL) released to Present positive updated ronde-cel data in More than 80 patients at 9:01 AM ET on Wednesday, November 4, and the stock went from Tuesday’s $10.77 close to as high as $16.73. It finished the session +43.3% at $15.43 on 6.9 times its 20-day average volume. The reaction describes the sequence and infers no cause.
What did Lyell Immunopharma announce on November 4, 2026?
Lyell Immunopharma (LYEL) released to Present positive updated ronde-cel data in More than 80 patients at 9:01 AM ET on Wednesday, November 4. The company’s release and its Form 8-K are linked in the sources on this page.
How did LYEL stock trade on November 4?
LYEL opened at $12.09, +12.3% from the prior close of $10.77, traded between $12.09 and $16.73 in the regular session and closed at $15.43, +43.3%, on 1.1M shares.
How did LiveChart’s stack read LYEL at the close on November 4?
At the 4:00 PM ET close the 5-minute stack bias on LYEL was neutral, Compass read “15m and 1h up” and Undertow read “volume surge”. Each turn of the read is on this page’s timeline.
What does LiveChart’s stack read on LYEL now?
The read on this page is fixed at each moment it describes. LiveChart reads LYEL on every bar as it trades: open it on LiveChart for the current stack bias, levels and every layer.
Every catalyst on LYEL
LYEL’s catalyst history
This is LYEL’s first Catalyst Reaction. Each time it moves on a release or a filing again, the reads line up here side by side, so how it reacts to its own news builds into a history.
| Session | The catalyst | The day | Next session | Stack bias at the close |
|---|---|---|---|---|
| Nov 4, 2026This reaction | To Present positive updated ronde-cel data in More than 80 patientsTrial data · 9:01 AM ET | +43.3% | −2.8% | Neutral |
Also on Wednesday, November 4
More Catalyst Reactions from that session
- Nov 48:45 AM ETPARA−88.3%Parabolic Technologies, Inc. Class A (PARA): a public offering, an 88.3% drop and a $0.0000 offeringOffering8.8× avg volume
- Nov 47:30 AM ETCNSY−31.4%Cerenome (CNSY): Secures National In-Network agreement with Aetna, a 31.4% drop and what followedCompany news1.6× avg volume
- Nov 45:36 PM ETHPAI+37.2%Helport AI (HPAI): advances Transition to autonomous AI Labor, a 37.2% session and what followedCompany news90.9× avg volume
- Nov 45:00 PM ETCMTG+66.7%Claros Mortgage Trust (CMTG): quarterly results, a 66.7% session and what followedEarnings33.1× avg volume
- Nov 44:10 PM ETTREE+32.8%LendingTree (TREE): quarterly results, a 32.8% session and what followedEarnings5.1× avg volume
- Nov 44:05 PM ETCRCT+48.7%Cricut (CRCT): quarterly results, a 48.7% session and what followedEarnings11.9× avg volume
Every Reaction From Nov 4More Trial Data ReactionsLYEL Catalyst HistoryLYEL on LiveChartTechnical Setups RadarAll Catalyst ReactionsIntraday Movers
Further reading: Gaps: continuation and exhaustionLow-float riskWhat VWAP tells youTrading around halts
General market information from the company’s releases, its SEC filings, the session’s prices and LiveChart’s reads. Prices are indicative. It describes what happened and when, infers no cause, takes no view on what comes next and is not a recommendation to buy or sell any security. Trigger trades are hypothetical. Read the Risk Disclosure.